ARE
$170.60
Alexandria Real Estate Equities
$2.87
1.71%
ARE
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  $1.84
Revenue:  $454.00 Mil
Monday
Feb 1
4:10 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ARE reports earnings?
Beat
Meet
Miss

Where is ARE's stock price going from here?
Up
Flat
Down
Stock chart of ARE
Analysts
Summary of analysts' recommendations for ARE
Score
Grade
Pivots
Resistance
$171.95
$170.40
$169.06

$167.51

Support
$166.17
$164.62
$163.28
Tweet
Growth
Description
Alexandria Real Estate Equities, Inc., Landlord and Developer of Choice to the Life Science Industry, is a publicly-traded real estate investment trust focused principally on the ownership, operation, management, selective redevelopment, development and acquisition of life science properties. Our properties are designed and improved for lease primarily to institutional, pharmaceutical, biotechnology, medical device, life science product, service, biodefense and translational medicine entities, as well as governmental agencies.
Peers
Boston PropertiesCoreSite RealtyPrologisSL Green RealtySimon Property GroupKimco RealtyMacerichFederal Realty Investment TrustAgree RealtyNational Retail Properties